Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI
Clinical trial NCT03924050 · COMPLETED
Trial details
- NCT number
- NCT03924050
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-06
- Primary completion
- 2024-10-21
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.